HATTERAS VENTURE PARTNERS
HATTERAS VENTURE PARTNERS is a Pre-seed, Seed and Series A fund in North Carolina, the US and Southeastern United States writing $500K–$5M checks into Healthcare, life-sciences, biopharmaceuticals, medical-devices, diagnostics and gene-therapy.
- Stages
- Pre-seed, Seed, Series A
- Sectors
- Healthcare, life-sciences, biopharmaceuticals, medical-devices, diagnostics, gene-therapy
- Check size
- $500K–$5M
- Invests in
- North Carolina, US-wide, Southeastern United States
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2000
- Assets under management
- $900M
- Website
- hatterasvp.com
Thesis
Hatteras Venture Partners, founded in 2000 and headquartered in Durham, NC, is a venture capital firm with over $900 million in capital across seven funds, specializing in healthcare and life sciences. Their investment thesis centers on seed and early-stage companies with strong scientific foundations, commercialization potential, and capable management. They focus on biopharmaceuticals, medical devices, diagnostics, and health technology, with a geographic emphasis on North Carolina and the Southeastern US, while also maintaining a national strategy. Hatteras typically invests $500,000 to $5 million initially, with potential for up to $20 million total, often taking a lead investor role and providing strategic guidance. In August 2025, they closed two new funds totaling over $200 million to continue supporting healthcare innovations from inception through growth stages.
Common questions
Does HATTERAS VENTURE PARTNERS invest at the Pre-seed stage?
Yes. HATTERAS VENTURE PARTNERS lists Pre-seed, Seed and Series A among the stages it invests in.
What check size does HATTERAS VENTURE PARTNERS write?
HATTERAS VENTURE PARTNERS writes $500K–$5M checks.
Where does HATTERAS VENTURE PARTNERS invest?
HATTERAS VENTURE PARTNERS invests in North Carolina, the US and Southeastern United States.